Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $441.06 million. The enterprise value is $350.13 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 294.04 million shares outstanding. The number of shares has increased by 9.48% in one year.
| Current Share Class | 294.04M |
| Shares Outstanding | 294.04M |
| Shares Change (YoY) | +9.48% |
| Shares Change (QoQ) | +6.26% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | 30.06% |
| Float | 147.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 108.46 |
| Forward PS | 15.72 |
| PB Ratio | 12.09 |
| P/TBV Ratio | 29.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 89.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.76, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.76 |
| Quick Ratio | 4.60 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15,784.17 |
Financial Efficiency
Return on equity (ROE) is -160.80% and return on invested capital (ROIC) is -69.80%.
| Return on Equity (ROE) | -160.80% |
| Return on Assets (ROA) | -39.95% |
| Return on Invested Capital (ROIC) | -69.80% |
| Return on Capital Employed (ROCE) | -76.53% |
| Revenue Per Employee | $27,448 |
| Profits Per Employee | -$882,762 |
| Employee Count | 143 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.63% in the last 52 weeks. The beta is 1.70, so Precigen's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | +5.63% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 49.93 |
| Average Volume (20 Days) | 1,427,525 |
Short Selling Information
The latest short interest is 23.90 million, so 8.13% of the outstanding shares have been sold short.
| Short Interest | 23.90M |
| Short Previous Month | 22.66M |
| Short % of Shares Out | 8.13% |
| Short % of Float | 16.25% |
| Short Ratio (days to cover) | 17.04 |
Income Statement
In the last 12 months, Precigen had revenue of $3.93 million and -$126.24 million in losses. Loss per share was -$0.47.
| Revenue | 3.93M |
| Gross Profit | -53.41M |
| Operating Income | -94.71M |
| Pretax Income | -97.34M |
| Net Income | -126.24M |
| EBITDA | -90.18M |
| EBIT | -94.71M |
| Loss Per Share | -$0.47 |
Full Income StatementBalance Sheet
The company has $97.91 million in cash and $5.50 million in debt, giving a net cash position of $92.41 million or $0.31 per share.
| Cash & Cash Equivalents | 97.91M |
| Total Debt | 5.50M |
| Net Cash | 92.41M |
| Net Cash Per Share | $0.31 |
| Equity (Book Value) | 38.51M |
| Book Value Per Share | 0.13 |
| Working Capital | 80.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$68.17 million and capital expenditures -$8.58 million, giving a free cash flow of -$76.76 million.
| Operating Cash Flow | -68.17M |
| Capital Expenditures | -8.58M |
| Free Cash Flow | -76.76M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,412.87% |
| Pretax Margin | -3,261.86% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.48% |
| Shareholder Yield | -9.48% |
| Earnings Yield | -28.53% |
| FCF Yield | -17.34% |
Analyst Forecast
The average price target for Precigen is $7.33, which is 388.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.33 |
| Price Target Difference | 388.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 160.61% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -19.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.77 |
| Piotroski F-Score | 2 |